BioArctic Sweden
09.01.2023 - 03:58:31BioArctic's partner Eisai submits supplemental Biologics License Application to FDA for traditional approval of LEQEMBI™ for the treatment of Alzheimer's disease
BioArctic's partner Eisai submits supplemental Biologics License Application to FDA for traditional approval of LEQEMBI™ for the treatment of Alzheimer's disease